Also, Roulois et al. showed that the anti-tumor effect of low-dose decitabine may depend on viral mimicry, activating MDA5/MAVS/IRF7 RNA recognition pathway in colorectal cancer-initiating cells [47], and its role in myeloid neoplasms need further investigation. This evidence concerns the gene IRF7 and colorectal cancer.